Entecavir Does Not Eliminate HCC Risk in Hepatitis B PatientsEntecavir Does Not Eliminate HCC Risk in Hepatitis B Patients
Patients taking entecavir for chronic hepatitis B are still at risk for hepatocellular carcinoma (HCC), a recent study suggests. Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Health | Hematology | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver Cancer | Study